Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 November 2020 | Story Dr Nitha Ramnath

In this webinar, Prof Brownhilder Neneh of the University of the Free State, and Christopher Rothmann, co-founder of LiquidCulture, discuss the intersection between the two fields of science and entrepreneurship, and entrepreneurship and the university curriculum from an interdisciplinary perspective. The webinar will provide insight into entrepreneurship at universities, particularly the UFS, advancing entrepreneurship development and entrepreneurship-related programmes that are student focused, and illustrate the critical role that entrepreneurship plays in the lives of students.

This webinar is part of a series of three webinars on Interdisciplinarity that is presented from November to December 2020 via Microsoft Teams for a duration of 45 minutes each. The webinar topics in the series explore the intersection between Neuroscience and Music, between Science and Entrepreneurship, and between Science and Visual Arts.  

Date: Tuesday 24 November 2020
Topic: The intersection between science and entrepreneurship 
Time: 13:00-13:45 (SAST)
RSVP: Alicia Pienaar, pienaaran1@ufs.ac.za by 23 November 2020 
Platform: Microsoft Teams

Introduction and welcome

Prof Corli Witthuhn 
Vice-Rector: Research at the University of the Free State 


Presenters

Prof Brownhilder Neneh 

Prof Neneh is Associate Professor and Academic Chair (HOD) in the Department of Business Management at the University of the Free State.  She is an NRF-rated researcher in the field of entrepreneurship and small business development. Her research is primarily based in the field of entrepreneurship, where she looks at different aspects of a business venture – from business gestation activities to performance, growth, and exit.  She also focuses on some niche areas in entrepreneurship, such as women and student entrepreneurship. She was a 2019 winner of the Emerald Literati Awards in the category Outstanding and Highly Commended papers. 

Christopher Rothmann – Co-founder of LiquidCulture

Liquid Culture (LC) was started by Christopher Rothmann and Dr Errol Cason in the UFS Department of Microbial, Biochemical and Food Biotechnology in 2018. They produce yeast in its purest liquid form. LC is the only company in Africa to do so. Their yeast is mainly used by breweries for the fermentation of beer and they have since also branched out to the baking and distillery industries. Christopher was awarded the joint runner-up position in the Existing Tech Business category of the 2019 Entrepreneurship Intervarsity.

News Archive

UFS researcher explores the future cost of cancer
2017-01-10

 Description: 001 Dr Alicia Sherriff Tags: 001 Dr Alicia Sherriff

Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.

Photo: Charl Devenish

Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.

Cancer is on the rise

There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.

The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.

Adoption of new strategies

According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.

Efficient solutions to curb cancer mortality

The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept